Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Interventional
Official Title: Rituximab for the Otolaryngologic Manifestations of Granulomatosis With Polyangiitis
Brief Summary: This is a phase IV, single-center, randomized, placebo-controlled pilot study that will evaluate the efficacy of rituximab at inducing otolaryngologic remission in GPA patients with active otolaryngologic disease.